Modulatory Effect of Dietary Inclusion of Aegle marmelos Fruits against Cisplatin – Induced Hepatotoxicity In Wistar Rats
Journal Title: Annals of Hepatology - Year 2018, Vol 17, Issue 3
Abstract
Introduction and Aim. Aegle marmelos is an important traditional herbal medicine used in India. The dietary inclusion of the plant has never exposed earlier for its hepatoprotective activity. This study aimed to investigate the modulator efficacy of dietary inclusion of Aegle marmelos against Cisplatin - induced hepatotoxicity in Wistar albino rats. Material and methods. Animals were divided into five different groups; Group I was given basal diets only, Group II was fed basal diets with Aegle marmelos in 4% concentration, while Group III was fed basal diets co-administered with Cisplatin. Group IV and V were administered diets containing 2 and 4% Aegle marmelos respectively, for 27 days prior to Cisplatin administration. Cisplatin was administered to the rats for 3 days leads to a reduction in the activities of the antioxidant enzymes like lipid peroxidation (LPO) and endogenous antioxidant systems such as reduced superoxide dismutase (SOD), glutathione (GSH) and catalase in liver homogenate caused to produce the impairment of hepatic functions. Results. The administration of fruit part of Aegle marmelos to Wistar rats showed a significant fall in the elevated Lipid peroxidation, superoxide dismutase, glutathione and catalase concentration, moreover, it diminished the increased serum level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), acid phosphatase (ACP) and bilirubin. Conclusions. We can conclude that the hepatoprotective activity of Aegle marmelos was due to its antioxidant effect as evidenced by increasing activity of antioxidant enzymes with enhanced hepatic function and significantly changed the physiological parameters.<br/><br/>
Authors and Affiliations
Saket S. Chandel, Mrunal Shirsat, Ram K. Sahu, Siva S. Nayak
Keywords
Related Articles
- EP ID EP345415
- DOI 10.5604/01.3001.0011.7393
- Views 110
- Downloads 0
Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-Two case reports
Pegylated interferon (Peg-IFN) in combination with ribavirin is the standard of care in the treatment of chronic hepatitis C (HCV). Peg-IFN is known to have a number of side effects but severe respiratory complications a...
Adult living donor versus deceased donor liver transplantation: A 10- year prospective single center experience
It has been 4 years since the first, long-term (&amp;gt; 3 years) prospective comparison of adult-to-adult living donor liver transplantation (A2ALLTx) to adult deceased donor liver transplantation (ADDLTx) was repor...
Reply to contribution on the topic of hypovitaminosis D in chronic hepatitis C
Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
[b]Introduction[/b]. Poor adherence to treatment for various chronic diseases is a frequent phenomenon. Current guidelines for the treatment of chronic hepatitis B (HBV) and hepatitis C (HCV) recommend optimal adherence,...
Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis
Objective. Angiotensin II, one component of renin-angiotensin system (RAS), is formed from Ang I by the catalysing of angiotensin converting enzyme (ACE). Angiotensin II plays an important role in the development of insu...